La chaîne d'options affiche les données clés des options sur actions de Karooooo à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Karooooo..

Karooooo (NASDAQ:KARO) Stock, Chaîne d'Options

Karooooo

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

<p>In what has been termed the most aggressive domestic spending rewrite in decades, <span style="box-sizing: border-box; margin: 0px; padding: 0px;">the U</span>.S. Senate<a href="https://www.benzinga.com/news/politics/25/07/46211326/one-big-beautiful-bill-passes-senate-with-jd-vances-tie-breaking-vote-trump-says-its-going-to-go-very-nicely-in-the-house"> passed a broad policy package</a> on Tuesday that reduces federal benefits for low-income Americans, redraws healthcare mandates, and, at the same time, sows the seeds of new equity exposure through so-called &#8220;Trump Accounts&#8221; for babies.</p>
<p>As the bill remains pending final passage in the House, market participants are already assessing how this fiscal reshaping might impact asset classes. ETFs, as ever, provide a window into which industries might take the hit or capture the gain.</p>
<h2 class="wp-block-heading">SNAP Decisions, Consumer Staples Dilemma</h2>
<p>One of the <a href="https://www.whitehouse.gov/articles/2025/05/fact-one-big-beautiful-bill-cuts-spending-fuels-growth/">bill's </a>headline features is a <a href="https://www.benzinga.com/news/financing/25/07/46215083/how-trumps-big-beautiful-bill-impacts-snap-medicaid-taxes-and-student-loans">drastic reduction in Supplemental Nutrition Assistance Program</a> (SNAP) funding—nearly $300 billion over the next decade. With more challenging work requirements and millions expected to drop off the rolls, the impact could show up in earnings for discount retailers, dollar stores, and low-margin grocery chains.</p>
<p>That brings <a href="https://www.benzinga.com/etfs">consumer staples ETFs</a><span style="box-sizing: border-box; margin: 0px; padding: 0px;"><a href="https://www.benzinga.com/etfs" target="_blank" rel="noopener">,</a> such as the <strong>Consumer Staples Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) and<strong> the Vanguard Consumer Staples Index Fund ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>),</span> into question. They feature powerhouse names such as <strong>Walmart </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) and<strong> Dollar General </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>), stocks with high exposure to lower-income consumers.</p>
<h2 class="wp-block-heading">Healthcare ETFs: Mandate, Interrupted</h2>
<p>The Medicaid overhaul is no less seismic. The bill mandates work requirements for able-bodied adults aged 19 to 64 and adds more paperwork hurdles, while slicing federal support by $1 trillion over 10 years. That could spell trouble for health insurers with high Medicaid exposure.</p>
<p>ETFs such as the <strong>iShares U.S. Healthcare Providers ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHF#NYSE">IHF</a>) or <span style="box-sizing: border-box; margin: 0px; padding: 0px;"><strong>the Health Care Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) could experience investor rotation when states are racing to change programs and losses in coverage accumulate—resulting in </span>12 million more uninsured in 2034, according to the Congressional Budget Office.</p>
<h2 class="wp-block-heading">&#8220;Trump Accounts&#8221;: Baby&#8217;s First ETF?</h2>
<p>As SNAP and Medicaid are threatened with cuts, the legislation creates the door to a whole new way of government-subsidized retail investing: &#8220;Trump Accounts.&#8221; These pilot accounts will invest $1,000 in a market-indexed stock fund for each baby born between 2025 and 2028, and parents can contribute up to $5,000 per year.</p>
<p>If rolled out <span style="box-sizing: border-box; margin: 0px; padding: 0px;">nati</span>onwide, this would be a modest yet symbolically influential demand driver for diversified market ETFs, such as the<strong> SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and the <strong>Vanguard Total Stock Market ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTI#NYSE">VTI</a>).</p>
<h2 class="wp-block-heading">Tax Cuts And Sector Tilts</h2>
<p>With the bill locking in the 2017 tax cuts and raising the child tax credit to $2,200 per child, increased disposable incomes, particularly for middle-class households, may support sectors related to discretionary spending. Investors might lean toward ETFs such as the <strong>Consumer Discretionary Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) or <strong>Vanguard Growth ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VUG#NYSE">VUG</a>), which contain retail and technology giants.</p>
<h2 class="wp-block-heading">State Burdens, Muni ETF Headaches</h2>
<p>States aren&#8217;t untouched. They will now pay 5% of SNAP benefits and 75% of administrative expenses, and they are penalized for excessive payment error rates. That could squeeze municipal finances, with ramifications for municipal bond ETFs such as the <strong>iShares National Muni Bond ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUB#NYSE">MUB</a>).</p>
<h2 class="wp-block-heading">When Washington Moves, Markets React</h2>
<p>This bill reminds investors that government spending isn't just a political debate—it's a market signal. Whether it's the squeeze on public benefits or the surprise boost for infant investors, ETFs are likely to reflect these tectonic shifts. For now, one thing's clear: when Washington rewrites the rules, Wall Street tends to reprice the playbook.</p>
<p><strong>Next Read: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/etfs/specialty-etfs/25/07/46226903/musk-plots-a-party-trump-fires-back-tesla-etfs-watch-the-fallout">Musk Plots A Party, Trump Fires Back, Tesla ETFs Watch The Fallout</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Broad U.S. Equity ETFs

ETFs

iShares Dow Jones US Health Care Provides Index Fund

iShares S&P National AMT-Free Municipal Bond Fund

Select Sector SPDR-Consumer Discretionary

Trump's Tax Blitz Is An ETF Game-Changer—Are You Ready?

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>AeroVironment</strong>.</p>
<p>Looking at options history for AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) we detected 21 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 47% with bearish.</p>
<p>From the overall spotted trades, 5 are puts, for a total amount of $339,640 and 16, calls, for a total amount of $705,935.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $110.0 to $290.0 for AeroVironment over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AeroVironment's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AeroVironment's whale trades within a strike price range from $110.0 to $290.0 in the last 30 days. </p>
<h3>AeroVironment Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751484012_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AVAV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$44.9</td>
<td>$43.8</td>
<td>$44.2</td>
<td>$290.00</td>
<td>$167.9K</td>
<td align="right">44</td>
<td align="right">40</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$13.9</td>
<td>$13.3</td>
<td>$13.85</td>
<td>$240.00</td>
<td>$69.0K</td>
<td align="right">418</td>
<td align="right">210</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$68.6</td>
<td>$66.7</td>
<td>$67.65</td>
<td>$200.00</td>
<td>$67.6K</td>
<td align="right">192</td>
<td align="right">10</td>
</tr>
<tr>
<td>AVAV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$65.8</td>
<td>$64.5</td>
<td>$64.5</td>
<td>$290.00</td>
<td>$64.5K</td>
<td align="right">30</td>
<td align="right">10</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$30.2</td>
<td>$29.3</td>
<td>$29.3</td>
<td>$230.00</td>
<td>$58.6K</td>
<td align="right">124</td>
<td align="right">60</td>
</tr>
</tbody>
</table>
</p>
<h3>About AeroVironment</h3>
<p>AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities.</p>
<p>After a thorough review of the options trading surrounding AeroVironment, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is AeroVironment Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 4,212,016, the AVAV's price is down by -2.61%, now at $245.81. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 63 days.</li>
</ul>
<h3>Expert Opinions on AeroVironment</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $270.2.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Raymond James downgraded its rating to Strong Buy, setting a price target of $225.<br />
&#x2A; An analyst from Goldman Sachs downgraded its action to Buy with a price target of $301.<br />
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on AeroVironment, which currently sits at a price target of $300.<br />
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for AeroVironment, targeting a price of $285.<br />
&#x2A; An analyst from Stifel downgraded its action to Buy with a price target of $240. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for AeroVironment, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

AVAV

What the Options Market Tells Us About AeroVironment

<p>Deep-pocketed investors have adopted a bullish approach towards Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RCL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 23 extraordinary options activities for Royal Caribbean Gr. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 69% leaning bullish and 17% bearish. Among these notable options, 3 are puts, totaling $147,430, and 20 are calls, amounting to $1,398,652.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $290.0 and $410.0 for Royal Caribbean Gr, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Royal Caribbean Gr's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Royal Caribbean Gr's whale trades within a strike price range from $290.0 to $410.0 in the last 30 days. </p>
<h3>Royal Caribbean Gr Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751484007_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.7</td>
<td>$14.1</td>
<td>$14.1</td>
<td>$400.00</td>
<td>$216.9K</td>
<td>152</td>
<td align="right">271</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.9</td>
<td>$13.9</td>
<td>$13.9</td>
<td>$400.00</td>
<td>$165.3K</td>
<td>152</td>
<td align="right">119</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$86.85</td>
<td>$84.7</td>
<td>$86.25</td>
<td>$290.00</td>
<td>$155.2K</td>
<td>37</td>
<td align="right">18</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$22.75</td>
<td>$21.15</td>
<td>$22.75</td>
<td>$310.00</td>
<td>$106.9K</td>
<td>1.1K</td>
<td align="right">47</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$56.15</td>
<td>$56.15</td>
<td>$56.15</td>
<td>$350.00</td>
<td>$101.0K</td>
<td>51</td>
<td align="right">18</td>
</tr>
</tbody>
</table>
</p>
<h3>About Royal Caribbean Gr</h3>
<p>Royal Caribbean is the world's second-largest cruise company by revenues, operating 67 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.</p>
<h3>Present Market Standing of Royal Caribbean Gr</h3>
<ul>
<li>With a trading volume of 1,799,691, the price of RCL is up by 2.86%, reaching $324.1.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 22 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Royal Caribbean Gr</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $319.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on Royal Caribbean Gr, which currently sits at a price target of $290.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on Royal Caribbean Gr, maintaining a target price of $318.<br />
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Royal Caribbean Gr with a target price of $310.<br />
&#x2A; Consistent in their evaluation, an analyst from Bernstein keeps a Outperform rating on Royal Caribbean Gr with a target price of $360. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Royal Caribbean Gr options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Royal Caribbean Gr

<p>High-rolling investors have positioned themselves bullish on Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CHWY often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 10 options trades for Chewy. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 60% bullish and 40% bearish. Among all the options we identified, there was one put, amounting to $65,455, and 9 calls, totaling $405,941.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $55.0 for Chewy, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Chewy's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chewy's whale trades within a strike price range from $30.0 to $55.0 in the last 30 days. </p>
<h3>Chewy Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751484001_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$45.00</td>
<td>$83.5K</td>
<td>2.4K</td>
<td align="right">201</td>
</tr>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.5</td>
<td>$12.35</td>
<td>$12.35</td>
<td>$52.50</td>
<td>$65.4K</td>
<td>55</td>
<td align="right">53</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$7.95</td>
<td>$7.75</td>
<td>$7.95</td>
<td>$47.50</td>
<td>$61.2K</td>
<td>72</td>
<td align="right">80</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$2.83</td>
<td>$2.7</td>
<td>$2.7</td>
<td>$39.00</td>
<td>$54.0K</td>
<td>5</td>
<td align="right">400</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.2</td>
<td>$4.15</td>
<td>$4.15</td>
<td>$40.00</td>
<td>$48.5K</td>
<td>10.0K</td>
<td align="right">125</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chewy</h3>
<p>Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.</p>
<p>Following our analysis of the options activities associated with Chewy, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Chewy</h3>
<ul>
<li>Trading volume stands at 4,567,823, with CHWY's price down by -0.07%, positioned at $41.83.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 56 days.</li>
</ul>
<h3>What The Experts Say On Chewy</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $46.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Guggenheim continues to hold a Buy rating for Chewy, targeting a price of $45.<br />
&#x2A; An analyst from Mizuho persists with their Neutral rating on Chewy, maintaining a target price of $44.<br />
&#x2A; An analyst from Mizuho downgraded its action to Neutral with a price target of $47.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Chewy, targeting a price of $46.<br />
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Chewy, maintaining a target price of $50. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Chewy with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


CHWY

Market Whales and Their Recent Bets on CHWY Options

<p>In the preceding three months, 7 analysts have released ratings for Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $63.0, along with a high estimate of $75.00 and a low estimate of $48.00. Witnessing a positive shift, the current average has risen by 10.53% from the previous average price target of $57.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483802_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Life360 by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Maria Ripps</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Chris Kuntarich</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$71.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$62.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Maria Ripps</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Chris Kuntarich</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$57.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Rob Sanderson</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$58.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$48.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Life360. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Life360 compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Life360's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Life360's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LIF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Life360 analyst ratings.</strong></a></p>
<h2>About Life360</h2>
<p>Life360 is the world's largest family-focused social network, with over 50 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.</p>
<h3>Financial Insights: Life360</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Life360 displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>32.47%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Life360's net margin excels beyond industry benchmarks, reaching <strong>4.22%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Life360's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>1.19%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Life360's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.98%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.0</strong>, Life360 adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

Breaking Down Life360: 7 Analysts Share Their Views

<p>During the last three months, 6 analysts shared their evaluations of Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high estimate of $84.00, and a low estimate of $54.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.26%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483786_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The standing of Legend Biotech among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashwani Verma</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$54.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$71.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Rick Bienkowski</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$84.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Legend Biotech. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Legend Biotech compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Legend Biotech's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Legend Biotech's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LEGN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Legend Biotech analyst ratings.</strong></a></p>
<h2>Delving into Legend Biotech's Background</h2>
<p>Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.</p>
<h3>Legend Biotech: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Legend Biotech showcased positive performance, achieving a revenue growth rate of <strong>107.52%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-51.74%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Legend Biotech's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-9.81%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-6.14%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.36</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LEGN

A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts

<p>In the latest quarter, 4 analysts provided ratings for Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.75, along with a high estimate of $26.00 and a low estimate of $22.00. Highlighting a 2.06% decrease, the current average has fallen from the previous average price target of $24.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483777_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A comprehensive examination of how financial experts perceive Lemonade is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jack Matten</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$23.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Tommy McJoynt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Underperform</td>
<td>$26.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Thomas McJoynt-Griffith</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$24.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Lemonade. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Lemonade compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Lemonade's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Lemonade's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LMND/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Lemonade analyst ratings.</strong></a></p>
<h2>Discovering Lemonade: A Closer Look</h2>
<p>Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.</p>
<h3>Lemonade: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Lemonade showcased positive performance, achieving a revenue growth rate of <strong>26.95%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Lemonade's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-41.27%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Lemonade's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-10.96%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Lemonade's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-3.37%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.23</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LMND

Beyond The Numbers: 4 Analysts Discuss Lemonade Stock

<p>Crypto markets are on the rise as renewed institutional demand fuels momentum, particularly after news that <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46228970/blackrocks-bitcoin-etf-surpasses-sp-500-etf-in-revenue-as-xrp-dogecoin-etf-approval-predicted-to-follow-soon">BlackRock's Bitcoin ETF is now generating more in fees</a> than its flagship S&amp;P 500 fund. This signals a significant shift in institutional investor focus toward digital assets. </p>
<p><figure class="wp-block-table"><br />
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Ticker</strong></td>
<td><strong>Price</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$109,391.56</td>
</tr>
<tr>
<td><strong>Ethereum</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,577.93</td>
</tr>
<tr>
<td><strong>Solana</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$151.97</td>
</tr>
<tr>
<td><strong>XRP</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.25</td>
</tr>
<tr>
<td><strong>Dogecoin</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1715</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001185</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume decreasing by 22.7% and daily active addresses growing by 5.4%. Transactions greater than $100,000 are down from 11,714 to 11,019 in a single day. Exchanges netflows are down by 68%.</li>
<li>Coinglass data reports 109,908 traders were liquidated in the past 24 hours for $350.52 million.</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46219486/microstrategy-of-ethereum-approach-gains-popularity-as-bitdigital-raises-163-million">&#8216;MicroStrategy Of Ethereum&#8217; Approach Gains Popularity As BitDigital Raises $163 Million</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46218569/jpmorgans-tests-carbon-credit-tokenization-on-the-blockchain">JPMorgan&#8217;s Tests Carbon Credit Tokenization On The Blockchain</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46215827/bitcoins-halving-cycle-is-over-standard-chartered-affirms-what-that-means-for-you">Bitcoin&#8217;s Halving Cycle Is &#8216;Over&#8217;, Standard Chartered Affirms: What That Means For You</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46217148/heres-why-altcoin-season-for-xrp-eth-sol-has-not-happened-yet">Here&#8217;s Why &#8216;Altcoin Season&#8217; For XRP, ETH, SOL Has Not Happened Yet</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/07/46208521/circle-crcl-stock-bank-bid-crypto-stablecoins">Circle&#8217;s Bank Bid Could Be The Biggest Crypto Story Of The Year</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46205649/bitcoin-fartcoin-outperform-in-2025-but-how-did-xrp-eth-solana-fare-in-the-first-6-months">Bitcoin, Fartcoin Outperform In 2025, But How Did XRP, ETH, Solana Fare In The First 6 Months?</a></li>
<li><a href="https://www.benzinga.com/markets/25/07/46214968/bitcoin-to-hit-200-000-in-2025-but-new-eth-sol-highs-remain-in-doubt-bitwise-says">Bitcoin To Hit $200,000 In 2025, But New ETH, SOL Highs Remain In Doubt, Bitwise Says</a></li>
</ul>
<p><strong>Top Gainers:</strong></p>
<p><figure class="wp-block-table"><br />
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Ticker</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
</tr>
<tr>
<td>SPX6900</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SPX</a>)</td>
<td>$1.28</td>
</tr>
<tr>
<td>Virtuals Protocol</td>
<td>(CRYPTO: VIRTUAL)</td>
<td>$1.62</td>
</tr>
<tr>
<td>Worldcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WLD</a>)</td>
<td>$0.9541</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes: </strong>Crypto trader Roman cautioned against overanalyzing Bitcoin's recent price moves, citing reduced market activity during the U.S. holiday week. "More than 50% of the workforce is likely on vacation," he noted, adding that low liquidity can produce misleading price action in either direction. "We'll get a better-read next week," he concluded.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Stated earlier this week I'd take any <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> movement with a grain of salt.<br /><br />It's a big holiday week here in the states. 50%+ of the workforce is on vacation.<br /><br />This applies to both up/down movement.<br /><br />Will get a better read next week. <a href="https://t.co/XrFLtMvfWm">pic.twitter.com/XrFLtMvfWm</a></p>
<p>&mdash; Roman (@Roman_Trading) <a href="https://twitter.com/Roman_Trading/status/1940469781163135330?ref_src=twsrc%5Etfw">July 2, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Meanwhile, CryptoCon <a href="https://x.com/CryptoCon_/status/1940439487458296138">remains</a> firm on his $166,000 target, citing the golden ratio extension, a model that has accurately forecasted previous cycle peaks. Though the timeline has shifted to September, the analyst believes the setup remains intact. "Just a 52% move left," he emphasized, pointing out that all cycle signals are still bullish.</p>
<p>Analyst Jackis added that Bitcoin is now trading at its lowest volatility since 2023, reaching levels only seen seven times in history. Each of those instances preceded a massive volatility spike, suggesting a major move is likely within five weeks.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> is hitting the lowest volatility since 2023 &amp; levels it only hit 7 times in history<br /><br />Here is what happened each time at these levels<br /><br />Explosion in volatility is coming up at max in 5 weeks if not sooner, that&#39;s for sure &#x1f525; <a href="https://t.co/q28uEqXBax">pic.twitter.com/q28uEqXBax</a></p>
<p>&mdash; JACKIS (@i_am_jackis) <a href="https://twitter.com/i_am_jackis/status/1940443558340931717?ref_src=twsrc%5Etfw">July 2, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>More Crypto Online <a href="https://x.com/Morecryptoonl/status/1940444543322820845">highlighted</a> a potential third wave breakout forming on the charts. With momentum increasing, he flagged $107,280 as the key support level. "Holding above it keeps the bullish structure intact," he said, adding: "Don't sleep on this move."</p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46220570/how-trumps-big-beautiful-bill-could-create-a-big-beautiful-bull-run-for-bitcoin-ethereum-xrp">How Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Could Create A &#8216;Big Beautiful Bull Run&#8217; For Bitcoin, Ethereum, XRP</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$DOGE

$ETH

$SHIB

$SOL

$SPX

$WLD

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Surge As 'Big Beautiful Bill' House Vote Nears

<p>As the greenback crawls through one of its <a href="https://www.benzinga.com/markets/economic-data/25/06/46146713/trump-dollar-outlook-tariffs-debt">worst first-half performances in decades</a>, investors are seeking both yield and shelter in global fixed income markets.</p>
<p>The <a href="https://www.benzinga.com/topic/us-dollar">U.S. dollar</a> has been under pressure, dragged down by increasing political uncertainty, lower-than-expected economic data, and a growing consensus for several Fed rate cuts this year. </p>
<p>The <strong>U.S. Dollar Index</strong> (DXY) dropped around 11% over the last six months, its sharpest decline since 1991. Although the fall of the dollar initially feels like bad news, it&#8217;s secretly laying the groundwork for global bond markets to make a comeback.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/forex/25/06/46175116/weaker-dollar-stocks-beneficiaries-foreign-revenue">Dollar&#8217;s Biggest Crash In Decades: These 7 Stocks Could Win Big</a></strong></p>
<h2 class="wp-block-heading">The Macro Math</h2>
<p>As U.S. interest rates decrease, yields on home-country bonds drop, making them less attractive compared to their foreign brethren. At the same time, a weakening dollar increases the value of foreign interest payments converted back into U.S. dollars. The pair creates fertile soil for foreign <a href="https://www.benzinga.com/etfs">fixed-income ETFs</a>, especially hedged foreign ones.</p>
<p>And that&#8217;s just where a select group of strategic ETFs steps in:</p>
<p><strong>iShares International Treasury Bond ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGOV#NASDAQ">IGOV</a>): This ETF offers exposure to non-U.S. developed market governments, such as those of Japan, France, Germany, and the U.K. Importantly, it targets sovereign debt of highly rated nations, providing a vehicle for investors to diversify their bond holdings outside of the U.S. Treasury market.</p>
<ol class="wp-block-list"></ol>
<ul class="wp-block-list">
<li>Top Holdings: Japanese Government Bonds, French OATs, and U.K. Gilts</li>
<li>Currency Exposure: Unhedged, with potential gains from foreign currency appreciation</li>
<li>Why Now: Foreign currency-denominated debt can benefit from valuation tailwinds with the dollar on the backfoot</li>
<li>Expense Ratio: 0.35%</li>
<li>IGOV is very attractive when global central banks are out of phase with the Fed, or when the dollar weakens and inflation is contained abroad. The fund gained more than 12% in H1.</li>
</ul>
<p><strong>Vanguard Total International Bond ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNDX#NASDAQ">BNDX</a>): This ETF is a currency-hedged, income-focused investment. For those investors seeking international exposure but wanting currency volatility kept at arm&#8217;s length, BNDX is an attractive solution. BNDX invests in non-US investment-grade bonds, with a blend of sovereign and corporate issuers, while actively hedging currency risk.</p>
<ol start="2" class="wp-block-list"></ol>
<ul class="wp-block-list">
<li>Key Holdings: Bonds issued by Japan, France, Germany, and the U.K.</li>
<li>Currency Strategy: Fully hedged to the US dollar</li>
<li>Why Now: In a declining-rate, high-volatility FX world, BNDX can provide stable income with reduced risk</li>
<li>Expense Ratio: 0.07% — one of the lowest in its category</li>
<li>Hedging by BNDX will keep you safe from the dangers of euro and yen whipsawing your returns—best for risk-averse income investors.</li>
</ul>
<h2 class="wp-block-heading">The Bigger Picture</h2>
<p>With investors increasingly doubting the dollar&#8217;s longer-term resilience and the Fed set to loosen policy again, perhaps now is the moment to turn to the rest of the world for fixed income. </p>
<p>Hedged (such as BNDX) or unhedged (such as IGOV), international bond ETFs offer a means of enhancing yield potential, diversifying away from U.S. credit risk, and capitalizing on evolving global macroeconomic trends.</p>
<p><strong>Read Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/etfs/specialty-etfs/25/07/46226903/musk-plots-a-party-trump-fires-back-tesla-etfs-watch-the-fallout">Musk Plots A Party, Trump Fires Back, Tesla ETFs Watch The Fallout</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Specialty ETFs

BNDX

iShares S&P/Citigroup International Treasury Bond Fund

IGOV

These ETFs Gain As Dollar Slips And Rate Cut Bets Rise

<p>Analysts' ratings for S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $594.0, a high estimate of $627.00, and a low estimate of $565.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.59%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483698_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A clear picture of S&amp;P Global's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$592.00</td>
<td>$567.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$603.00</td>
<td>$629.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$627.00</td>
<td>$607.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$589.00</td>
<td>$616.00</td>
</tr>
<tr>
<td>Alex Kramm</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$575.00</td>
<td>$555.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$607.00</td>
<td>$633.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$565.00</td>
<td>$618.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to S&amp;P Global. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of S&amp;P Global compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of S&amp;P Global's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into S&amp;P Global's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SPGI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on S&amp;P Global analyst ratings.</strong></a></p>
<h2>Discovering S&amp;P Global: A Closer Look</h2>
<p>S&amp;P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&amp;P's largest segment by profitability. S&amp;P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&amp;P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.</p>
<h3>Understanding the Numbers: S&amp;P Global's Finances</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> S&amp;P Global's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>8.19%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> S&amp;P Global's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>28.86%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> S&amp;P Global's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>3.28%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>1.81%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.36</strong>, S&amp;P Global adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SPGI

The Analyst Verdict: S&P Global In The Eyes Of 7 Experts

<p>Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Texas Roadhouse, presenting an average target of $185.91, a high estimate of $220.00, and a low estimate of $164.00. A decline of 1.68% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483674_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A comprehensive examination of how financial experts perceive Texas Roadhouse is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$212.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$205.00</td>
<td>$184.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$200.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$164.00</td>
<td>$213.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$179.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$170.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$198.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Texas Roadhouse. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Texas Roadhouse compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Texas Roadhouse's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Texas Roadhouse's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/TXRH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Texas Roadhouse analyst ratings.</strong></a></p>
<h2>Discovering Texas Roadhouse: A Closer Look</h2>
<p>Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.</p>
<h3>Texas Roadhouse: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Texas Roadhouse's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>9.57%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>7.85%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>8.3%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>3.56%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.66</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TXRH

Assessing Texas Roadhouse: Insights From 11 Financial Analysts

<p><strong>United Parcel Service </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) is strategically navigating a challenging economic landscape, focusing intensely on internal efficiencies and cost reduction to bolster profitability and deliver higher returns for investors.</p>
<p><strong>Bank of America</strong> analyst Ken Hoexter reiterated the Buy rating on United Parcel Service on Wednesday, with <a href="https://www.benzinga.com/quote/UPS/analyst-ratings" target="_blank" rel="noreferrer noopener">a price forecast of $115</a>.</p>
<p>Hoexter described United Parcel Service<strong> </strong>as one of the three global integrators offering exposure to e-commerce growth, historically trading at mid-to-upper teens Price-to-Earnings (PE) multiples (previously low 20s), supported by mid-20s Return on Invested Capital (ROIC) levels, though recent pressure has emerged.</p>
<p><strong><em>Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46032308/alibaba-expands-ai-cloud-footprint-in-south-korea-with-new-data-hub-launching-in-june" rel="noreferrer noopener">Alibaba Expands AI Cloud Footprint In South Korea With New Data Hub Launching In June</a></em></strong></p>
<p>This particular target multiple reflects several key positive developments: the company is anticipated to have moved beyond its trough EPS, is actively concentrating on divesting low-margin operations, and is aggressively implementing measures to reduce its structural costs.</p>
<p>With its emphasis on pricing, e-commerce, and global sourcing, and its tendency to move in line with the broader economy, the analyst maintained a Buy rating, citing the company&#8217;s strong focus on cost and revenue management.</p>
<p>Despite this, Hoexter reduced second quarter of 2025, 2025, and 2026 EPS projections by 5%-8% to $1.52, $7.00, and $7.70, respectively, citing margin pressure from lost de minimis international express volumes, the phased removal of <strong>Amazon.com, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) revenues by mid-2026, and a slow macro recovery.</p>
<p>Per Hoexter, United Parcel Service stock has stayed near the lower end of its 15x–21x historical range amid tariff impacts and Amazon volume declines, though the company continues cutting structural costs.</p>
<p>International margin forecast was lowered to 14.2% from 16%, as US-China volumes dropped more than expected; while other routes are helping, the lost lane was among the most profitable.</p>
<p>The removal of the de minimis rule and April tariff hikes drove a major volume drop.</p>
<p>Domestic margin was slightly adjusted to 7.3% from 7.4%, still in line with United Parcel Service&#8217;s view, reflecting mild operating leverage. Hoexter added that the broader demand environment remains subdued.</p>
<p>Hoexter noted that BofA&#8217;s Truck Shipper Survey Demand Indicator, closely correlated with ISM Manufacturing, remains near freight recession levels, with the latest reading at 54.9, just above the 54.2 average of past downturns in 2012, 2015, and 2019, and still below the 60 growth threshold.</p>
<p>The analyst highlighted that since the freight recession began in April 2022, the company&#8217;s shares have lagged, dropping 45%, compared to a 38% gain in the S&amp;P 500 and a 17% rise in FedEx.</p>
<p><strong>Price Action: </strong>UPS shares are trading higher by 0.59% to $105.09 at last check Wednesday.</p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46220764/stellantis-under-new-federal-recall-investigation-for-gear-shifter-issue" target="_blank" rel="noreferrer noopener"><em>Stellantis Under New Federal Recall Investigation For Gear Shifter Issue</em></a></strong></li>
</ul>
<p><em>Image via Shutterstock</em></p>


Analyst Color

Reiteration

Trading Ideas

General

AMZN

UPS Streamlines Operations, Cuts Costs For Higher Returns

<p>During the last three months, 14 analysts shared their evaluations of Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $276.86, with a high estimate of $360.00 and a low estimate of $220.00. This current average represents a 0.94% decrease from the previous average price target of $279.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751483643_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Royal Caribbean Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Clarke</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$318.00</td>
<td>$268.00</td>
</tr>
<tr>
<td>Steven Wieczynski</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$310.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$290.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Robin Farley</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$311.00</td>
<td>$301.00</td>
</tr>
<tr>
<td>Patrick Scholes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$275.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>Paul Golding</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$265.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jamie Rollo</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$230.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$263.00</td>
<td>$249.00</td>
</tr>
<tr>
<td>Christopher Stathoulopoulos</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$275.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$245.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$249.00</td>
<td>$308.00</td>
</tr>
<tr>
<td>Jamie Rollo</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$220.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Steven Wieczynski</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$265.00</td>
<td>$310.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Royal Caribbean Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Royal Caribbean Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Royal Caribbean Gr's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Royal Caribbean Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/RCL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Royal Caribbean Gr analyst ratings.</strong></a></p>
<h2>Delving into Royal Caribbean Gr's Background</h2>
<p>Royal Caribbean is the world's second-largest cruise company by revenues, operating 67 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.</p>
<h3>Unraveling the Financial Story of Royal Caribbean Gr</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Royal Caribbean Gr displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>7.27%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Royal Caribbean Gr's net margin is impressive, surpassing industry averages. With a net margin of <strong>18.25%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Royal Caribbean Gr's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>9.41%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.96%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Royal Caribbean Gr's debt-to-equity ratio is below the industry average at <strong>2.53</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing Royal Caribbean Gr: Insights From 14 Financial Analysts

<p>In the current session, <strong>AstraZeneca Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>)</strong> is trading at $71.17, after a <strong>0.41%</strong> decrease. Over the past month, the stock fell by <strong>2.51%</strong>, and in the past year, by <strong>7.98%</strong>. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1751483364_0.png" alt="Past Year Chart" /></p>

<h3>AstraZeneca P/E Compared to Competitors</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Compared to the aggregate P/E ratio of <strong>27.38</strong> in the Pharmaceuticals industry, AstraZeneca Inc. has a higher P/E ratio of <strong>28.76</strong>. Shareholders might be inclined to think that AstraZeneca Inc. might perform better than its industry group. It's also possible that the stock is overvalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1751483364_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

Price Over Earnings Overview: AstraZeneca

<p><a href="https://www.bloomberg.com/news/articles/2025-07-02/oracle-openai-ink-stargate-deal-for-4-5-gigawatts-of-us-data-center-power" title="https://www.bloomberg.com/news/articles/2025-07-02/oracle-openai-ink-stargate-deal-for-4-5-gigawatts-of-us-data-center-power">https://www.bloomberg.com/news/articles/2025-07-02/oracle-openai-ink-stargate-deal-for-4-5-gigawatts-of-us-data-center-power</a></p>


MSFT

ORCL

'Oracle, OpenAI Expand Stargate Deal for More US Data Centers' - Bloomberg News

<p>William Blair  analyst Myles Minter   initiates coverage on Dianthus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNTH#NASDAQ">DNTH</a>) with a Outperform rating.</p>


Initiation

DNTH

William Blair Initiates Coverage On Dianthus Therapeutics with Outperform Rating

<p><strong>Green Brick Partners's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRBK#NYSE">GRBK</a>) short percent of float has risen 8.44% since its last report. The company recently reported that it has <strong>1.26 million shares sold short</strong>, which is 4.11% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 5.13 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Green Brick Partners Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751482832_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Green Brick Partners has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Green Brick Partners's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Green Brick Partners's peer group average for short interest as a percentage of float is 8.42%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

GRBK

Is the Market Bullish or Bearish on Green Brick Partners?

<p><strong>UDR's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) short percent of float has risen 20.16% since its last report. The company recently reported that it has <strong>7.14 million shares sold short</strong>, which is 2.92% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.61 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>UDR Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751482826_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for UDR has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing UDR's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, UDR's peer group average for short interest as a percentage of float is 3.91%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


What's Driving the Market Sentiment Around UDR?

<p><strong>O'Reilly Automotive's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NYSE">ORLY</a>) short percent of float has risen 1241.67% since its last report. The company recently reported that it has <strong>13.62 million shares sold short</strong>, which is 1.61% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.53 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>O'Reilly Automotive Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751482821_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for O'Reilly Automotive has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing O'Reilly Automotive's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, O'Reilly Automotive's peer group average for short interest as a percentage of float is 10.59%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Comments

Karooooo

Karooooo (KARO) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL